Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Melanoma 35Uveal Melanoma 9Prostatic Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Skin Neoplasms 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Lung Neoplasms 1Leukemia 1Fallopian Tube Neoplasms 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1Adenoma, Islet Cell 1

Interventions

Cisplatin 30Pemetrexed 21Gemcitabine 11Radiotherapy 6Nivolumab 6Drug Therapy 6Cyclophosphamide 6Carboplatin 6durvalumab 4Vinorelbine 4Chemotherapy, Adjuvant 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3sodium thiosulfate 3sargramostim 3Ipilimumab 3Doxorubicin 3raltitrexed 2pembrolizumab 2cediranib 2SS1(dsFv)PE38 2Radiotherapy, Intensity-Modulated 2Psychiatric Rehabilitation 2Photochemotherapy 2Neoadjuvant Therapy 2Methotrexate 2Interferon-alpha 2Imatinib Mesylate 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gefitinib 2Everolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mesothelioma, Malignant × incomplete Freund's adjuvant × Clear all
NCT00398138 2016-03-02

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
22 enrolled 7 charts
MyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Leukemia, Lung Neoplasms, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡